FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...
New York Fed President John Williams identifies AI-driven demand as the main inflation threat, warning that persisten...
Analysts debate whether $150 won’t hurt broadcom’s near-term earnings, as Broadcom’s AI backlog powers growth. The bu...
CrowdStrike is set to report Q1 results after the close, with analysts expecting revenue around $1.39 billion and sol...
A quirky NYC art project turned a moment of hype into a budgeting lesson. Discover how a $25 'Pocket Garbage' cube sp...
In March 2026, smart japan investors choosing hedged exposure via DXJ are gaining ground as currency moves and reform...
Investors watched Ford stock sink this week as the company faced a mix of softer sales signals, strategic bets on ene...
A June selloff tested leverage in Bitcoin-backed corporate debt, but the market has steadied. Dividend payments persi...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
As stocks climb, a warning from the former chair of the Federal Reserve signals risk ahead. This guide explains the t...
When berkshire hathaway just made a surprising Alphabet bet, investors sit up and take notice. This article explains ...